News

Basis Medical announced the completion of the first-in-human clinical procedures using the company’s Seclusion catheter to t ...
Vektor Medical, a medical technology company transforming standard ECG data into actionable insights that guide arrhythmia ...
Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...
Vektor Medical doses first patients in IMPRoVED-AF study using vMap to guide effective atrial fibrillation ablation: San Diego Friday, July 11, 2025, 15:00 Hrs [IST] San Diego-hea ...
Kardium announced today that it raised $250 million in a new financing round to support the launch of its pulsed field ...
Introduction: Currently, the treatment of atrial fibrillation (AF) focuses on restoring sinus rhythm with pulmonary vein isolation (PVI). Pulsed-field ablation (PFA) is a novel, promising method that ...
Boston Scientific (NYSE: BSX) announced that the FDA approved an expansion to the label of its Farapulse pulsed field ablation (PFA) system.
Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the ...
Targeted ablation guided by voltage mapping improved rhythm outcomes in individuals with recurrent atrial fibrillation after ...
The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...